The city of San Antonio, Texas, currently has 13 active clinical trials seeking participants for Atopic Dermatitis research studies.
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Recruiting
The purpose of this study is to assess the pharmacokinetics (PK), efficacy, and safety of nemolizumab in pediatric participants with moderate-to-severe atopic dermatitis (AD).
Gender:
ALL
Ages:
Between 2 years and 12 years
Trial Updated:
04/05/2023
Locations: Galderma Investigational Site #78218-3128, San Antonio, Texas
Conditions: Moderate-to-Severe Atopic Dermatitis